Factors influencing FDA drug approval decisions beyond clinical trial evidence: a scoping review

Health Affairs Scholar · Published 2026-08-04 · DOI 10.1093/haschl/qxag201

Free full text

Authors (4)

Robin Forrest, Martin Lodge, Ameet Sarpatwari, Huseyin Naci

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Forrest, R., Lodge, M., Sarpatwari, A., et al. (2026). Factors influencing FDA drug approval decisions beyond clinical trial evidence: a scoping review. Health Affairs Scholar. https://doi.org/10.1093/haschl/qxag201

Related articles

• Randomized communication nudges to increase primary care engagement among Medicaid enrollees in Maine · Health Affairs Scholar · 2026 · Same journal
• Over-the-counter emergency contraceptive sales before and after Dobbs : a difference-in-difference analysis of US retail data · Health Affairs Scholar · 2026 · Same journal
• Drug and country characteristics associated with global approval and launch of FDA-approved novel therapeutics · Health Affairs Scholar · 2026 · Same journal
• The impact of Medicaid expansion on coverage among those lacking housing basics, 2010-2019 · Health Affairs Scholar · 2026 · Same journal
• Medicaid Payment Policies for Methadone Maintenance Treatment for Opioid Use Disorder, 2020-2025 · Health Affairs Scholar · 2026 · Same journal
• Employee preferences in health plan design: results from a national survey · Health Affairs Scholar · 2026 · Same journal
• Minimizing H.R.1-related Medicaid coverage disruptions for high-risk patients · Health Affairs Scholar · 2026 · Same journal
• Separation from the CDC and its consequences for the public health workforce: findings from the CDC WISE Survey · Health Affairs Scholar · 2026 · Same journal
• Universal Free School Meals and Medicaid Spending: Evidence from Linked Education and Claims Data in Arkansas · Health Affairs Scholar · 2026 · Same journal
• An evaluation of the US public–private Combating Antibiotic-Resistant Bacteria Accelerator (CARB-X) initiative · Health Affairs Scholar · 2026 · Same journal